|Project name: ||Shingles Immunisation Programme - there are 2 reports for this project: 2014, 2015 |
|Google search: ||Google search on project name (opens in new window) |
|Organisation: ||DOH (D12) - see all reports for this organisation |
|Report year: ||2015 (data is from Sept 2014) |
|Category: ||Transformation - see all reports for this category |
|Description: ||Background: shingles is caused by the reactivation of the chicken pox virus in a person with a dormant chicken pox infection. Shingles incidence is highest in older people as the incidence of shingles increases with age. Prior to immunisation being introduced in the UK, there were estimated to be around 790 to 880 cases per 100,000 people, an estimated 30,000 cases of shingles for people aged 70 79 each year. In 2010, JCVI advised that a universal shingles programme should be implemented for people aged 70 years to 79 years inclusive if a licensed vaccine was available at a cost effective price. The Department of Health (DH) has a legal obligation, under the 2010 NHS Constitution, to offer new vaccines to the public that are recommended by JCVI and which are shown to be cost effective.
Objective: The overarching objective of introducing shingles vaccination is the reduction of shingles and associated sequaelae in England.
Scope: The scope of the project is limited to England and includes all the elements required to successfully deliver a shingles vaccination and catch up programme.
Benefits: The programme is delivering: (1) sustained improvements in public health; (2) a reduction in burden on the NHS by reducing the need for treatment and (3) a cost effective health intervention.
Status: shingles vaccination was introduced on 1 September 2013. In 2013/14 shingles vaccination was offered to 70 year olds (the routine cohort) and 79 year olds (the catch-up cohort). In 2014/15 shingles immunisation is being offered to all those aged 70, 78 and 70. The catch-up programme will be continued progressively in future years so that all people aged 70-79 years are offered shingles vaccination. |
|DCA (RAG): ||Green |
|DCA text: ||The MPA RAG rating was Green at Q2 2014.
The delivery confidence assessment has been set at Green as shingles immunisation was successfully introduced on schedule on 1 September 2013. Vaccine uptake in the first full year of the programme was 62% for 70 year olds and 60% for 79 year olds. A GMPP Exit Review was carried out in November 2014 and the Major Projects Authority has decided that this programme should be removed from the GMPP. |
|Start date: ||2012-12-11 |
|End date: ||2013-11-01 |
|Schedule text: ||There have been no deviations from the planned schedule. |
|Baseline: ||£67.34m |
|Forecast: ||£67.34m |
|Variance: ||0.00% |
|Variance text: ||Budget variance less than 5% |
|Whole Life Cost: ||£171.53m |
|WLCost text: ||The budgeted whole life costs (WLC) set out in the Q2 2014/15 GMPP return are estimates from the Full Business Case to implement the programme as a whole, including vaccine purchase costs borne by PHE and vaccine administration costs borne by NHS England. The business case was approved by HM Treasury on 3 November 2012. The WLC figure has not changed since the equivalent transparency report in 2013/14. |
|Notes1: || DOH NON CAPITAL |
|Notes2: || |
|Sourcefile: ||IPA_2015.csv |
All Projects (+dates)
All Projects (+costs)
Acknowledgement: GMPP data has been re-used under the Open Government Licence.